Cargando…

Mitigating prolonged QT interval in cancer nanodrug development for accelerated clinical translation

BACKGROUND: Cardiac toxicity is the foremost reason for drug discontinuation from development to clinical evaluation and post market surveillance [Fung 35:293-317, 2001; Piccini 158:317-326 2009]. The Food and Drug Administration (FDA) has rejected many potential pharmaceutical agents due to QT prol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ranjan, Amalendu P, Mukerjee, Anindita, Helson, Lawrence, Vishwanatha, Jamboor K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878673/ https://www.ncbi.nlm.nih.gov/pubmed/24330336 http://dx.doi.org/10.1186/1477-3155-11-40

Ejemplares similares

Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy
por: Ranjan, Amalendu P, et al.
Publicado: (2012)

Development of Biodegradable Nanocarriers Loaded with a Monoclonal Antibody
por: Gdowski, Andrew, et al.
Publicado: (2015)

Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
por: Gdowski, Andrew S., et al.
Publicado: (2017)

Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain
por: Gdowski, Andrew S, et al.
Publicado: (2017)

Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials
por: Gdowski, Andrew, et al.
Publicado: (2018)

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023)

Beyond a prolonged QT interval
por: Bitar, Zouheir Ibrahim, et al.
Publicado: (2013)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

Multifactorial QT Interval Prolongation and Takotsubo Cardiomyopathy
por: Gysel, Michael, et al.
Publicado: (2014)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Azithromycin: QT interval prolongation: case report
Publicado: (2021)

Chloroquine: QT interval prolongation: case report
Publicado: (2021)

Prolonged QT Interval in Cirrhosis: Twisting Time?
por: Lee, William, et al.
Publicado: (2022)

Prolonged QT interval in a man with anorexia nervosa
por: Macías-Robles, María Dolores, et al.
Publicado: (2009)

Correlation between seizure in children and prolonged QT interval
por: Sadrnia, Saeid, et al.
Publicado: (2013)

Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update
por: Niemeijer, Maartje N., et al.
Publicado: (2015)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

Characterizing QT interval prolongation in early clinical development: a case study with methadone
por: Dubois, Vincent F. S., et al.
Publicado: (2017)

QT Interval Prolongation in Patients with Systemic Sclerosis—Are the Holter ECG Recordings a Better Option for QT Interval Evaluation?
por: Saramet, Elena E., et al.
Publicado: (2021)

QT-interval prolongation due to medication found in the preoperative evaluation
por: Seto, Mika, et al.
Publicado: (2017)

Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2021)

Prognostic significance of prolonged corrected QT interval in cerebral contusion
por: Yavuz, Ahmed Yasin, et al.
Publicado: (2023)

Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes
por: Ninkovic, Vladan M., et al.
Publicado: (2016)

Concentration‐QT modelling shows no evidence of clinically significant QT interval prolongation with capivasertib at expected therapeutic concentrations
por: Voronova, Veronika, et al.
Publicado: (2021)

Dabigatran Does Not Prolong the QT Interval with Supratherapeutic Exposure: a Thorough QT Study in Healthy Subjects
por: Ring, Arne, et al.
Publicado: (2013)

QT interval prolongation after sertraline overdose: a case report
por: de Boer, Rudolf A, et al.
Publicado: (2005)

High incidence of severely prolonged QT interval after cardiac surgery
por: Biry, M, et al.
Publicado: (2010)

Severe QT interval prolongation associated with moxifloxacin: a case report
por: Koide, Tetsuro, et al.
Publicado: (2008)

Evaluation of Ondansetron-induced QT interval prolongation in the prophylaxis of postoperative emesis
por: Gupta, Sampa Dutta, et al.
Publicado: (2011)

Does Artesunate Prolong the Electrocardiograph QT Interval in Patients with Severe Malaria?
por: Maude, Richard J., et al.
Publicado: (2009)

Prolonged Corrected QT Interval in Patients with Myotonic Dystrophy Type 1
por: Park, Kang Min, et al.
Publicado: (2013)

Editorial: Safety Pharmacology – Risk Assessment QT Interval Prolongation and Beyond
por: Grandi, Eleonora, et al.
Publicado: (2018)

Coprescription of QT interval-prolonging antipsychotics with potentially interacting medications in Thailand
por: Waleekhachonloet, Onanong, et al.
Publicado: (2019)

The Effects of Trimetazidine on QT-interval Prolongation and Cardiac Hypertrophy in Diabetic Rats
por: Ramezani-Aliakbari, Fatemeh, et al.
Publicado: (2019)

Adrenal insufficiency causes life-threatening arrhythmia with prolongation of QT interval
por: Komuro, Jin, et al.
Publicado: (2015)

QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine
por: Malone, Katie, et al.
Publicado: (2020)

Incident prolonged QT interval in midlife and late-life cognitive performance
por: Suemoto, Claudia K., et al.
Publicado: (2020)

Early Identification of Prolonged QT Interval for Prevention of Sudden Infant Death
por: Sarquella-Brugada, Georgia, et al.
Publicado: (2021)

Transient Acquired QT Interval Prolongation After Administration of Intravenous Ondansetron
por: Mao, Ruochen, et al.
Publicado: (2021)

Does pulmonary vein isolation prolong QT-interval?— Authors’ reply
por: Hermans, Ben J M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fupn0mb90h3c8gsot383q6cpj0